Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma

Chondrosarcoma is the most common bone sarcoma in adults. Conventional chondrosarcoma, the commonest histological subtype, is largely resistant to anthracycline-based chemotherapy. There have been anecdotal reports of durable clinical benefit with antiangiogenic agents in this disease. A retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Robin L., Katz, Daniela, Loggers, Elizabeth T., Davidson, Darin, Rodler, Eve T., Pollack, Seth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574947/
https://www.ncbi.nlm.nih.gov/pubmed/28852958
http://dx.doi.org/10.1007/s12032-017-1030-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574947/
https://www.ncbi.nlm.nih.gov/pubmed/28852958
http://dx.doi.org/10.1007/s12032-017-1030-2

Ejemplares similares